ARAlexey G. Ryazanov

Alexey G. Ryazanov

*This is an algorithmically generated author record based on publicly available information.

Alexey G. Ryazanov has a total of 14 co-authors. Here are the top co-authors by number of shared publications:

  • Alexander Vasil’eVich Efimov

    Institute of Protein Research, Russian Academy of Sciences, Institutskaya St., 4, Pushchino, Moscow Region 142290 Russia

    1 shared publication
  • Eileen White

    Rutgers Cancer Institute, Rutgers University, New Brunswick, USA

    1 shared publication
  • Hsueh-Ping Chu

    The Department of Pharmacology, Robert Wood Johnson Medical School, and the Department of Molecular Biology, Massachusetts General Hospital, Department of Genetics, Harvard Medical School, Boston, Massachusetts 02114

    1 shared publication
  • Inna A. Nikonorova

    Department of Genetics and Human Genetics Institute of New Jersey, Rutgers, The State University of New Jersey , Piscataway, NJ 08854

    1 shared publication
  • Jason J. Merkin

    The Department of Pharmacology, Robert Wood Johnson Medical School, and

    1 shared publication
  • Jianmin Chen

    The Department of Cell Biology and Neuroscience, Rutgers University, Piscataway, New Jersey 08854

    1 shared publication

Latest Publications

  • Open Access

    Agonists in the Extended Conformation Stabilize the Active State of β-Adrenoceptors

    by Alexander V. Efimov, Olga V. Meshcheryakova, Alexey G. Ryazanov

    In this study, we conducted a comparative analysis of the structure of agonists and antagonists of transmembrane (TM) β-adrenoceptors (β-ARs) and their interactions with the β-ARs and proposed the mechanism of receptor activation. A characteristic feature of agonist and antagonist molecules is the presence of a hydrophobic head (most often, one or two aromatic rings) and a tail with a positively charged amino group. All β-adrenergic agonists have two carbon atoms between the aromatic ring of the head and the nitrogen atom of the amino group. In antagonist molecules, this fragment can be either reduced or increased to four atoms due to the additional carbon and oxygen atoms. The agonist head, as a rule, has two H-bond donors or acceptors in the para - and meta -positions of the aromatic rings, while in the antagonist heads, these donors/acceptors are absent or located in other positions. Analysis of known three-dimensional structures of β-AR complexes with agonists showed that the agonist head forms two H-bonds with the TM5 helix, and the tail forms an ionic bond with the D3.32 residue of the TM3 helix and one or two H-bonds with the TM7 helix. The tail of the antagonist can form similar bonds, but the interaction between the head and the TM5 helix is much weaker. As a result of these interactions, the agonist molecule acquires an extended “strained string” conformation, in contrast to the antagonist molecule, which has a longer, bended, and flexible tail. The “strained string” of the agonist interacts with the TM6 helix (primarily with the W6.48 residue) and turns it, which leads to the opening of the G protein-binding site on the intracellular side of the receptor, while flexible and larger antagonist molecules do not have the same effect on the receptor.


  • Open Access

    Paradoxical Roles of Elongation Factor-2 Kinase in Stem Cell Survival

    by Yi Liao, Hsueh-Ping Chu, Zhixian Hu, Jason J. Merkin, Jianmin Chen, Zuguo Liu, Kurt Degenhardt, Eileen White, Alexey G. Ryazanov


  • Open Access

    Identification of a Mg2+-sensitive ORF in the 5′-leader of TRPM7 magnesium channel mRNA

    by Inna A. Nikonorova, Nikolay V. Kornakov, Sergey E. Dmitriev, Konstantin S. Vassilenko, Alexey G. Ryazanov

    TRPM7 is an essential and ubiquitous channel-kinase regulating cellular influx of Mg2+. Although TRPM7 mRNA is highly abundant, very small amount of the protein is detected in cells, suggesting post-transcriptional regulation of trpm7 gene expression. We found that TRPM7 mRNA 5′-leader contains two evolutionarily conserved upstream open reading frames that act together to drastically inhibit translation of the TRPM7 reading frame at high magnesium levels and ensure its optimal translation at low magnesium levels, when the activity of the channel-kinase is most required. The study provides the first example of magnesium channel synthesis being controlled by Mg2+ in higher eukaryotes.